|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Toxocara canis IgG ELISA | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Progesterone (17OH) ELISA Assay | Progesterone RIA CT Assay |
| Citations | | | | | |
| Catalog Number | IB79828 | TM09003 | TM09036 | IB79334 | KIP1458 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Toxocara canis IgG ELISA is intended for the determination of IgG class antibodies against Toxocara canis in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Infliximab (Remicade®, Remsima®, and Inflectra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay for the in-vitro diagnostic quantitative determination of 17-OH-progesterone in human serum and plasma (EDTA). The assay is intended for in vitro diagnostic use by professional users only. Manual processing is recommended. The usage of laboratory automats is the user’s sole Enzyme immunoassay for the in-vitro diagnostic quantitative determination of 17-OH-progesterone in human serum and plasma (EDTA). The assay is intended for in vitro diagnostic use by professional users only. Manual processing is recommended. The usage of laboratory automats is the user’s sole responsibility.... Read More | Radioimmunoassay (RIA) for the quantitative measurement of human Progesterone (PROG) in serum. FDA registered 510(k) Exempt. For In-Vitro Diagnostic Use. |
| Detection Target | Toxocara canis IgG | Prolactin | sAPP Total | IGF-1 | Progesterone |
| Sample Type | Serum and plasma (citrate, heparin). | Serum, Blood Plasma | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | Calculated cut-off value used to interpret results of unknowns. | 0 / 1 - 30 ng/mL | Anti-Ustekinumab (Stelara®) | 0.1 to 25.0 ng/mL | 0.12 to 36 ng/mL |
| Sensitivity | 96.92% (95% confidence interval: 89.32% - 99.63%). | 0.35 ng/mL | 0.06 ng/mL | 0.091 ng/mL | 0.05 ng/mL |
| Assay Time | 1 hour incubation (37°C) + 30 min. (RT) + 15 min. (RT) = 1 hour, 45 min. total incubation time. | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 1 hr 30 mins (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |